Cingulate Inc. Business Finance Contracts & Agreements
53 Contracts & Agreements
- Note Agreements (11 contracts)
- Purchase Agreements (7)
- Registration Rights Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (4)
- Warrant Agreements (25)
- Form of Placement Agent Warrant (Filed With SEC on July 1, 2024)
- Form of March 2024 WFIA Pre-Funded Warrant (Filed With SEC on April 1, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on February 7, 2024)
- Form of Placement Agent Warrant (Filed With SEC on February 7, 2024)
- Form of Series B Warrant (Filed With SEC on February 7, 2024)
- Form of Series A Warrant (Filed With SEC on February 7, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 7, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 29, 2024)
- Form of Placement Agent Warrant (Filed With SEC on January 29, 2024)
- Form of Series B Warrant offered hereby (Filed With SEC on January 29, 2024)
- Form of Series A Warrant offered hereby (Filed With SEC on January 29, 2024)
- Form of Pre-Funded Warrant offered hereby (Filed With SEC on January 29, 2024)
- Note Conversion Agreement, dated January 25, 2024, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on January 29, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 29, 2024)
- Note Conversion Agreement, dated September 8, 2023, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on September 11, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on September 11, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on September 7, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on August 29, 2023)
- Form of Placement Agent Warrant (Filed With SEC on August 29, 2023)
- Form of Series B Warrant offered hereby (Filed With SEC on August 29, 2023)
- Form of Series A Warrant offered hereby (Filed With SEC on August 29, 2023)
- Form of Pre-Funded Warrant offered hereby (Filed With SEC on August 29, 2023)
- Form of Underwriter Warrant (Filed With SEC on August 22, 2023)
- Form of Series B Warrant offered hereby (Filed With SEC on August 22, 2023)
- Form of Series A Warrant offered hereby (Filed With SEC on August 22, 2023)
- Form of Pre-Funded Warrant offered hereby (Filed With SEC on August 22, 2023)
- Form of Underwriting Agreement (Filed With SEC on August 22, 2023)
- Securities Purchase Agreement, dated August 11, 2023, by and between the Company and Werth Family Investment Associates LLC (Filed With SEC on August 14, 2023)
- Amended and Restated Promissory Note, dated May 9, 2023, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on May 10, 2023)
- Registration Rights Agreement, dated April 24, 2023, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on April 25, 2023)
- Purchase Agreement, dated April 24, 2023, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on April 25, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 10, 2023)
- Form of Pre-Funded Warrant to be offered hereby (Filed With SEC on March 10, 2023)
- Form of Warrant to be offered hereby (Filed With SEC on March 10, 2023)
- Promissory Note, dated August 9, 2022, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on August 11, 2022)
- Form of Nonqualified Stock Option Award under 2021 Plan (Filed With SEC on May 12, 2022)
- Form of Warrant Agency Agreement (Filed With SEC on November 30, 2021)
- Form of Warrant (Filed With SEC on November 30, 2021)
- Form of Underwriting Agreement (Filed With SEC on November 30, 2021)
- Form of Underwriter Warrant (Filed With SEC on November 10, 2021)
